Greg Mullen

Icahn School of Medicine at Mount Sinai

Papers

2

Total Citations

18

H-Index

2

About

Dr. Greg Mullen is a pioneering urologic surgeon whose research centers on advancing minimally invasive surgical techniques, particularly in kidney transplantation and pain management. His most impactful work introduced the first-ever robotic single-port donor nephrectomy using the da Vinci SP® Surgical System, a landmark study (16 citations) that demonstrated the feasibility and safety of this novel approach for living kidney donors, potentially reducing surgical trauma and recovery time. Dr. Mullen also leads clinical trials in perioperative care, notably the UROTAP randomized trial comparing robot-assisted transversus abdominis plane blocks against ultrasound-guided and local anesthesia methods to optimize pain control and minimize narcotic use in urologic procedures. His contributions bridge surgical innovation and patient-centered outcomes, earning recognition for expanding the boundaries of robotic surgery. With a focus on translating cutting-edge technology into practical, safer surgical options, Dr. Mullen’s work continues to shape the future of urologic surgery and transplant medicine.

Research Focus

Key Achievements

2
H-Index
2
Papers
18
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Single-Port Donor Nephrectomy with the da Vinci SP® Surgical System
16 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago